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In general, the native fold of a protein in a given environment is 
unique and at a global free-energy minimum [1]. However, some 
proteins spontaneously undergo substantial fold switching and 
reversibly transit between several conformers: “metamorphic” 
proteins [2]. Unfortunately, identifying and examining such proteins 
is a challenge because they are highly dynamic and impossible to 
identify a priori [3]. In contrast, minor rearrangement often occurs in 
single-domain enzymes upon binding of substrates, as shown for 
proteolytic enzymes of the metallopeptidase (MP) class [4]. As to 
enzymatic activity, an increase in enzyme concentration usually 
raises activity, as more substrate can be bound and turned over [5]. 
Here we describe a metamorphic minimal selective and specific 
caseinolytic metallopeptidase, selecase, which shows reversible and 
concentration-dependent equilibrium between different discrete 
states and an associated loss of enzymatic activity due to 
autoinhibition. 
We recently discovered a family of soluble minimal MPs named 
“minigluzincins” and characterized two of them, proabylysin and 
projannalysin, but we only isolated them as inactive zymogens, each 
in a single conformation [6]. In the present study, we introduce 
selecase from Methanocaldococcus jannaschii as a novel family 
member. We recombinantly produced and purified selecase (see 
Experimental Procedures [EP] and Supplemental Results and 
Discussion [SRD] in the Supporting Information for details). In 
contrast to the other minigluzincins, the 110-residue full-length 
selecase corresponded to a mature, fully active MP with narrow and 
selective—hitherto unreported—substrate specificity that cleaved 
bovine milk casein at a single site on its !s1 chain (Suppl. Fig. 1 and 
Suppl. Tables 1-2).  
Selecase was extremely soluble in aqueous buffer and did not 
precipitate at 130mg/ml. Thus, we studied the concentration-
dependent enzymatic activity of selecase on a peptide that mimics 
the casein cleavage site (peptide CCS). Normally, peptide-bond 
hydrolysis by MPs is an ordered single-displacement reaction, 
which follows simple Michaelis-Menten kinetics [7]. This entails that 
higher enzyme concentrations enhance the initial rate of reaction in the 
pre-steady state following a hyperbolic curve until a plateau is reached 
upon saturation [5]. This is found e.g. with tobacco-etch virus 
proteinase, which is widely used in biotechnology (Fig. 1a).  
 
Figure 1. A polyoligomeric metallocaseinase with abnormal activity. (A) Proteolytic activity 
of wild-type selecase on peptide CCS (green curve). Tobacco-etch virus proteinase mutant 
S219V, which shows comparable catalytic efficiency to selecase but normal concentration-
dependent activity, is shown for comparison (purple curve). (B) SEC-MALLS of selecase at 
selected initial concentrations (0.15-65mg/ml; see also Suppl. Fig. 2b). The peak pattern moves 
towards smaller elution volumes with increasing protein concentration, thus suggesting protein 
oligomerization. Curves are colored according to the inset in panel (D). (C) Analytical 
ultracentrifugation curves at six selected concentrations depicting the concentration-dependent 
oligomeric populations. Essentially, monomers are predominantly found at 0-0.3mg/ml; dimers at 
0.3-2mg/ml; tetramers at 2-6mgl; and octamers at >6mg/ml. (D) SAXS intensity profiles, I(s), as 
a function of the momentum transfer, s, measured for wild-type selecase at selected 
concentrations (see Suppl. Fig. 3 for all curves). Profiles have been displaced along the I(s) axis 
for comparison. The experimental scattering curves at the three lowermost concentrations 
studied indicate a mixed population of monomers and dimers based on the crystallographic 
structures of slc1 and slc2 (black curves).  
Surprisingly, although selecase activity did indeed increase with 
concentration between 0.025-0.25mg/ml, it fell sharply thereafter to 
become only residual at 50mg/ml. Most interestingly, this inactive 
concentrated selecase regained maximal activity following simple 
dilution with buffer. Accordingly, selecase showed reversible 
enzymatic autoinhibition due to changes in concentration—and not to 
inhibition by the substrate or any other reagent—, which to our 
knowledge is novel for peptidases. 
Subsequently, we explored oligomerization of selecase in solution in 
the concentration range 0.15-65mg/ml using several biophysical 
techniques (see EP and SRD for full details). Briefly, calibrated size-
exclusion chromatography (SEC) revealed monomers, dimers, 
tetramers, and octamers in variable amounts depending on the 
concentration (Suppl. Fig. 2a). SEC-MALLS, which combines SEC 
with multi-angle laser light scattering (MALLS), revealed two average 
populations of ~25KDa and ~80KDa, possibly corresponding, 
respectively, to dimeric and octameric selecase but also additional 
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Figure 2. Competent monomer vs. incompetent dimers. (A) Ribbon plot of slc1 in 
standard orientation [8]. Helices (!1, !B, and !2-!4) are shown in pink, "-strands ("1-"3) in 
magenta, and loops/coils in purple. For extent and nomenclature of regular secondary 
structure elements, see Suppl. Table 7. Selected residues are shown for their side chains, as 
is the catalytic metal ion (magenta sphere). The NTS and the CTS are shown over light green 
and light purple background, respectively. (B) Surface representation of slc1 colored 
according to Kyte-Doolittle hydrophobicity (blue=hydrophilic over white to 
orange=hydrophobic) in the same orientation as in (A) showing the active-site cleft with the 
hydrophobic S1’ specificity pocket. (C) Superposition of slc1 (in pink) and the slc2 monomer 
(in cyan). Depicted are the respective metal ions, which are shifted relative to each other 
(purple arrow). Horizontal black arrows pinpoint the anchor points around which the 
conformational rearrangement occurs. (D) Overall structure of symmetric dimeric slc2—
chains in cyan and gold—depicted so that the crystallographic dyad (black horizontal ellipses 
joined by a line) is in the plane of the picture. (E) Superposition of slc1 (in pink) and molecule 
B of the R36W selecase dimeric mutant (slc2’; in light green). Magenta arrows pinpoint the 
side chain movement at position 36 owing to the mutation and the 50º-rotation of C-terminal 
helix !4. (F) Structure of the asymmetric dimer of slc2’ consisting of helix-rotated molecule B 
(green) and close-to-native molecule A (orange). Both active-site clefts are blocked but 
following different mechanisms. Note the two W36 side chains at the interface. (G) 
Superposition of slc1 (in pink) and one of the two equivalent close-to-native monomers of 
selecase I100F+ H107F dimeric mutant (slc2’’; in purple). (H) Inactive dimer of slc2’’(in purple 
and red). 
species such as monomers and tetramers (Fig. 1b and Suppl. Fig. 2b). 
Sedimentation velocity analytical ultracentrifugation revealed the 
concentration-dependent presence of four oligomeric species, which 
would be consistent with monomers, dimers, tetramers, and 
octamers. This was backed by equilibrium velocity experiments 
showing concentration-dependent average masses ranging between 
monomers+dimers and octamers (Fig. 1c and Suppl. Table 3). 
Chemical crosslinking experiments followed by SDS-PAGE, in turn, 
showed monomers, dimers, monomer-dimer complexes, and 
tetramers. Higher oligomerization species were not detected due to 
intrinsic experimental limitations (Suppl. Fig. 2c). Circular 
dichroism spectra of selecase, with either zinc or nickel in the catalytic 
site, displayed the typical shape of well-folded mostly "-helical 
proteins (Suppl. Fig. 2d). Finally, SAXS revealed that the protein did 
not aggregate at concentrations of up to 65mg/ml (Suppl. Table 4, Fig. 
1d, Suppl. Figs. 3 and 4). These results further showed that the relative 
population of the oligomeric species in solution was concentration 
dependent. In addition, single value decomposition analysis of the 
SAXS dataset indicated that four species (monomers, dimers, 
tetramers, and octamers) were present. 
Summarizing, biophysical analyses in solution indicated the 
presence of mixtures of monomers, dimers, tetramers and octamers, 
with higher concentrations leading to greater oligomerization but not 
indiscriminate aggregation or precipitation. The concentrations at 
which monomeric selecase was predominant coincided with those of 
maximal enzymatic activity (0.2-0.3mg/ml; Fig. 1a), thus indicating 
that the monomer is the active species and that oligomers correspond 
to self-inhibiting species in all cases (see below). This would explain 
why higher enzyme concentrations yielded lower activity (Fig. 1a) and 
is reminiscent of previous reports on oligomerization inhibiting 
activity of phospholipase A2 [9]. Notably, simple dilution with buffer 
reversed oligomerization to yield monomers and restore activity. 
To identify the molecular determinants of this behavior, we 
crystallized and solved the structure of wild-type selecase (see EP, 
SRD and Suppl. Table 5). We obtained three crystal forms—
orthorhombic, tetragonal, and hexagonal—, which serendipitously 
corresponded, respectively, to monomeric (slc1), dimeric (slc2) and 
tetrameric (slc4) forms of selecase. This indicated that at least three of 
the oligomerization states found in solution had a counterpart in the 
form of a stable, isolatable species, each one favored by particular 
crystallization conditions. The crystal structure of monomeric slc1 
reveals—by comparison with several functional but otherwise 
unrelated MPs—that the overall architecture, the metal-binding site, 
and the active-site environment are consistent with a competent and 
functional mature enzyme (see [7b, 10]). This conclusion is supported by 
the enzymatic activity found for selecase in solution being associated 
with a monomeric species (see above). It is also reinforced by SAXS 
for which the experimental scattering curves at the three lowermost 
concentrations—covering the activity maximum of the enzyme—
clearly indicated mixed populations of monomers and dimers based on 
the crystallographic coordinates of slc1 and slc2 (see below), with the 
monomeric fraction at the two lowermost concentrations reaching 70% 
(see Fig. 1d, SRD and Suppl. Figs. 3-4).  
At 13.1 KDa, slc1 is the smallest active peptidase structurally 
characterized to date and it has a compact globular shape of ~35-40Å 
in diameter (Fig. 2a). It consists of an upper N-terminal sub-domain 
(NTS; residues M1-Y76) and a lower C-terminal sub-domain (CTS; 
G77–K109), which are connected by a mostly hydrophobic interface 
(Suppl. Table 6) and separated by a horizontal central active-site cleft 
(Fig. 2b). The NTS is an !/"-sandwich, with a three-stranded mixed "-
sheet ("1-"3; Suppl. Table 7) that forms the roof of the selecase 
moiety (Fig. 2a). Two roughly parallel !-helices (“backing helix” !1 
and “active-site helix” !2) are attached to the convex surface of the 
sheet, which faces the central core of the protein. A short helical 
segment (“linking helix” !B) is inserted in the loop connecting strand 
"3 with helix !2 (L"3!2). Helix !2 roughly parallels the active-site 
cleft and ends with the last residue of the NTS at Y76. It encompasses a 
metal binding motif, H69-E70-X-X-H73, which is characteristic of MPs 
and includes two metal-binding histidines and a general base/acid 
glutamate essential for catalysis [11]. Residue H80, imbedded within 
L!2!3 of the CTS, is the third metal ligand. The CTS mainly consists 
of two helices (“glutamate helix” !3 and “C-terminal helix” !4), 
whose axes intersect at ~90º. Helix !3 contains F84 at the center of the 
“Ser/Gly-turn” [6, 11a], which creates a hydrophobic base for the metal-
binding site and contributes to its stabilization. The active-site cleft of 
selecase is framed by helix !2; “upper-rim” strand "2 of the NTS sheet 
and the preceding “bulge-edge segment” (L34-I38); helices !3 and !4; 
and L!2!3, in particular through the side chains of K78 and Y79. The 
catalytic metal ion resides at the bottom left of the cleft (Fig. 2a,b). At 
its right, a deep hydrophobic S1’ pocket is shaped by I38, A39, F65, I66, 
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L102 and the solvent-accessible ring surface of H69. This pocket 
optimally accommodates a phenylalanine in the P1’ position of 
substrates as found at the casein cleavage site. The slc1 moiety is 
held together by a central hydrophobic core, which traverses the 
entire molecule, and several of the contributing residues also shape 
the NTS-CTS interface (Fig. 2a and Suppl. Table 6).  
The crystal structure of slc2 shows a dimer (Suppl. Table 8), and 
superposition of slc1 and slc2 monomers reveals good overall fit, 
with only minor differences within the NTS (see Fig. 2c). However, 
major metamorphic rearrangement is observed around the metal-
binding site (see Fig. 2c and Suppl. Movie 1). In slc2, at the 
beginning of CTS, L!2!3 folds outward between G77 and I81, with a 
maximal displacement of ~7Å. This causes the third metal-binding 
protein residue in slc1, H80, to swing out and protrude from the 
molecular surface. This, in turn, leads to an upward shift of the 
catalytic metal towards the general base/acid E70 (Fig. 2c). Two 
selecase monomers associate through C2 symmetry under occlusion 
of a large surface (2,130Å2; see Suppl. Table 8 and Fig. 2d) and so 
the third metal-binding site is taken over by H107 from helix !4 of 
the symmetric molecule. Accordingly, this H80/H107 ligand swap is 
an intermolecular event that yields a catalytically incompetent 
metal-binding site and a blocked active-site cleft in slc2. This is 
consistent with oligomerization states higher than a monomer 
coinciding with inactive species in solution (see above). 
As in slc2, the protomer of tetrameric slc4 shows good overall fit 
with slc1 within the NTS, including the position and conformation of 
most side chains at the NTS-CTS interface. However, both major 
displacement and drastic conformational rearrangement are 
observed in the CTS (see Fig. 3a and Suppl. Movie 2). The segment 
of the active-site helix with the first two metal ligands undergoes 
slight displacement (Fig. 3a). Downstream loop L!2!3 and 
glutamate helix !3—which is virtually unchanged in both slc1 and 
slc2—unfold and give rise to strands "4 and "5, which adopt a 
canonical "-ribbon structure (Fig. 3a and Suppl. Table 7). Such long 
stretches of a protein only rarely undergo such dramatic transitions 
[12]. The "-ribbon protrudes away from the molecular moiety (Fig. 
3a,b), as a result of which metal-ligand H80 shifts ~16Å from its 
position in slc1 and no longer binds the metal. In contrast with !3, 
the C-terminal helix !4 keeps its helical structure but is displaced 
~30Å apart on average in slc4 (Fig. 3a). Overall, this metamorphic 
structural transition of selecase is stabilized by the association of 
four monomers in the crystal (Fig. 3b-d, Suppl. Table 8, and Suppl. 
Movie 2), which would explain tetrameric oligomerization in 
solution (see above). The oligomer is a compact, almost spherical 
self-inhibitory particle of ~60-75Å in diameter (Fig. 3c,d). One 
monomer (chain A) interacts through D2 symmetry—by hiding a 
total interface of 9,850Å2—with two neighboring molecules (chains 
B and D) through mixed hydrophobic/hydrophilic contacts, and with 
one opposite monomer (chain C) through hydrophobic contacts 
(Suppl. Table 8). Two large elliptical openings (minor axis ~16Å, 
major axis ~21Å; Fig. 3d and Suppl. Movie 2) on opposite faces of 
the particle are framed by upper-rim strands "2 and L"5!4 of two 
vicinal monomers (AB and CD). Access to the particle lumen 
through these entrances is limited by the respective "-ribbons, which 
protrude away from the particle surface and do not contact each 
other. The central lumen of the particle features a channel of ~50Å 
in length and ~15Å in diameter and allocates two internal dimetallic 
zinc-binding sites. Each of them results from the fusion of two 
neighboring metal sites as originally found in slc1 (chains AD and 
BC, respectively), with the two metal ions of each site ~3Å apart 
(Fig. 3b,d). Overall, this new conformation radically alters the 
structural segments that shape the S1’ pocket and the active-site cleft 
in competent slc1 and, thus, indicates that, like slc2, the tetrameric 
slc4 structure corresponds to an inactive species. This, again, is 
consistent with tetramers coinciding with inactive species in solution. 
Given the importance of the C-terminal helix !4 and loop L"1"2 
in oligomerization, we selected residues R36, I100, I103, and H107, 
which had been observed to participate in dimerization in slc2 and  
 
Figure 3. A compact autoinhibitory tetrameric particle. (A) Superposition of slc1 and slc4 
monomers in pink (magenta metal ion) and turquoise (blue metal ion), respectively, in the view 
of Fig. 2a. Only the distinct secondary structure elements of slc4 are labeled (see also Suppl. 
Table 7). Relevant residues undergoing major rearrangement are displayed for both structures 
and labeled. The metal is shifted downwards (red arrow). (B) Within the slc4 tetramer, two 
neighbor monomers as in (A), in turquoise (chain A; metal in blue) and light green (chain D; 
metal in yellow), bind over a crystallographic dyad perpendicular to the plane of the picture. 
This gives rise to a non-functional dimetallic zinc site bound by H69 and H73 of either monomer. 
(C) Two dimers as in (B), in turquoise/light green (chains A and D) and white/dark gray (chains 
B and C), associate face to face under a relative 90º-rotation to yield the overall tetrameric 
particle, with two dimetallic zinc sites in the particle lumen. (D) Surface representation of (C) 
after clipping off the frontal part to delineate the central particle channel. Only the dimetallic 
site depicted in (B) is shown for clarity. 
tetramerization in slc4 (Suppl. Table 8), and generated a total of seven 
single, double and triple point mutants in an attempt to ablate the 
interactions responsible for oligomerization and thus obtain 
monomeric forms. In addition, we constructed two deletion mutants 
targeting !4, respectively lacking four (slc#C4) and eight (slc#C8) C-
terminal residues. Moreover, we cloned two close orthologs from 
Methanotorris igneus and Methanocaldococcus fervens, which can be 
envisaged as natural fivefold and 19-fold point mutants of selecase 
(see EP and SRD for full details). All protein variants were produced, 
purified, and concentrated similarly to the wild type except for slc#C4, 
which was obtained with lower yields and could only be maximally 
concentrated to 5.0mg/ml, and slc#C8, which was insoluble and was 
discarded. This finding pointed to a stabilizing effect of helix !4 on 
the whole protein despite its overall flexibility in the various structures 
analyzed. Despite differences in the oligomer populations, all mutants 
revealed a concentration-dependent equilibrium between monomers, 
dimers, tetramers and octamers and a reduction in activity as 
concentration increased, similar to the wild type (Suppl. Fig. 5). These 
results indicate that selecase is highly plastic, which allows it to adapt 
to potentially deleterious point mutations and retain its capacity to 
oligomerize. 
This plasticity is backed by further structural studies. Out of all the 
aforementioned mutants and orthologs, we managed to crystallize 
variants R36W (hereafter slc2’) and I100F+H107F (hereafter slc2’’) and 
solved their crystal structures (see Figs. 2e-h and Suppl. Movie 3). 
Most interestingly, slc2’ showed a novel dimeric quaternary structure, 
distinct from slc2, which displayed each protomer in a different 
conformation despite chemical identity of the molecules. One 
molecule (A) essentially displays the conformation of functional 
monomeric slc1, including the metal site and the active-site cleft. It 
only differs significantly from the latter at L"1"2, which, owing to 
the side-chain replacement at position 36, causes the entire loop and 
thus the latter side chain to undergo major rearrangement towards the 
molecular moiety. The other molecule (B) also essentially coincides 
with slc1 but just after the glutamate helix. Hereafter, a 90º-rotation 
around bond N-C! of K95 results in C-terminal helix !4 being rotated 
as a rigid body by 50º so as to approach and thus sterically block its 
own active site cleft on its primed side. This further causes H107 to 
bind the catalytic metal, as observed in slc2, except that here this is an 
intramolecular rather than an intermolecular event (compare Figs. 2d 
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and 2e,f). This novel conformation of a selecase variant in 
molecule B is stabilized by an asymmetric interaction between C-
terminal helices with molecule A triggered by an edge-to-face 
interaction of the W36 side chains (Fig. 2f). This arrangement, in 
turn, causes the active-site cleft of molecule A to be blocked for 
substrate access by helix !B of molecule B, with Y57 of the latter 
interacting with the S1’ pocket of molecule A. The metal-binding 
site of the latter, in contrast, is unaffected. Accordingly, slc2’ 
corresponds—like slc2—to an inhibited conformation.  
As to slc2’’, superposition of the two essentially identical 
monomers in the asymmetric unit onto slc1 revealed a 
conformation that was close to the functional wild-type monomer, 
except that the end of the C-terminal helix was slightly unwound 
and more flexible owing to the two point mutations (Fig. 2g). 
However, the two phenylalanine residues at positions 100 and 107 
make two slc2’’ monomers symmetrically bind mainly through their 
respective C-terminal helices, which run roughly parallel to each 
other. As a result the non-primed sides of the active-site clefts are 
occluded and the phenylalanine rings at position 100 penetrate, 
respectively, the S1’ specificity pocket of the symmetric partner, as 
this residue matches the specificity of the enzyme. Further 
symmetric contacts are observed between the F107 side chain of one 
molecule and loop L"1"2 of the other, which enhance the overall 
flexibility of these regions. Accordingly, the structure of slc2’’ 
provides yet another mechanism of inhibition of selecase: in this 
case merely by shielding of the cleft (Fig. 2h). Thus, the two 
crystal structures of slc2’ and slc2’’ may represent genuine dimeric 
conformations of the mutants triggered by the respective side-chain 
replacements, as none of the respective structures was trapped in 
crystals of wild-type protein. This entails that replacement of just 
one and two residues, respectively, leads to two new structures of 
selecase (thus totaling five), supporting the metamorphic character 
of this protein. 
Summarizing, we succeeded in identifying and probing for the 
first time the structural transitions of a natural metamorphic protein 
with a multi-funnel folding energy landscape. Although 
metamorphic proteins may be encoded by a relevant fraction of all 
genomes, the lack of bioinformatics or structural approaches to 
identify them from the sequence restricts their discovery to 
serendipity. Consistently, to our knowledge 3D structural evidence 
for their existence has only been published for two natural proteins 
[2, 13], which just flip between two folds: ubiquitin protein ligase 
inhibitor Mad2 [14] and the chemokine lymphotactin [15]. In selecase, 
the energy basins are occupied by distinct fully-structured and 
stable states and not by unfolded species or molten globules (Fig. 4 
and Suppl. Movies 1-3). One conformer is catalytically competent 
and the others are incompetent but they coexist in equilibrium. 
These transitions between species are triggered by major 
rearrangement after residue G77 at the NTS-CTS interface, and they 
mainly affect the CTS. This is consistent with each sub-domain 
corresponding to a distinct folding unit or foldon [16] and the sub-
domain interface acting as a reversible zipper. The high flexibility 
of CTS was further verified by computational analysis of local 
conformational frustration and inter-domain flexibility assessment 
based on the elastic network model (see SRD and Suppl. Fig. 7). In 
addition, the thermodynamic consistency of interconversion was 
further backed by calculated geometric and thermodynamic 
parameters of solvation free energy of folding and of dissociation, 
as well as compactness, for wild-type selecase structures (see SRD 
and Suppl. Table 8). The inherent flexibility of the CTS avoids 
kinetic trapping in an irreversible misfolded state during 
conversion between alternate conformers through the protein-
protein interactions of oligomeric species as previously suggested 
for metamorphic proteins [13]. In our view, it is a striking 
observation that simple dilution/concentration of a sample at room 
temperature triggers fold switches that cause repacking of a 
hydrophobic core and exposure of new binding surfaces, which in 
turn generate spontaneous conversion between active monomers 
and inactive oligomers. This finding indicates that the energy 
barriers separating the minima are surmountable and that 
interconversion may proceed without passing through fully unfolded 
states [2], as suggested by the finding of largely conserved NTS 
foldons. Finally, our results also provide the first evidence for a 
peptidase with reversible, strictly concentration-dependent reduction 
of activity upon concentration increase, which is triggered by 
sequestering the competent conformation in incompetent but 
structured oligomers. This system affords a switch that provides a 
unique and reversible mechanism of control of catalytic activity in 
nature. 
 
 
Figure 4. Scheme illustrating the topology of the distinct selecase structures reported. A 
black ellipse stands for a dyad vertical to the plane, two black ellipses connected by a line 
stand for a dyad in the plane. NTS, N-terminal sub-domain; histidines H69, H73, H80 and H107 
are shown. In slc2’, R
36 is replaced by tryptophan; in slc2’’, I
100 and H107 are replaced by 
phenylalanine. 
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Multiple Stable Conformations Account 
for Reversible Concentration-Dependent 
Oligomerization and Autoinhibition of a 
Metamorphic Metallopeptidase. 
Molecular plasticity controls enzymatic activity: the native fold of a protein 
in a given environment is normally unique and in a global free-energy 
minimum. Some proteins, however, spontaneously undergo substantial fold 
switching to reversibly transit between defined conformers, the 
“metamorphic” proteins. Here, we present a minimal metamorphic, 
selective and specific caseinolytic metallopeptidase, selecase, which 
reversibly transits between several different states of defined three-
dimensional structure, which are associated with loss of enzymatic activity 
due to autoinhibition. The latter is triggered by sequestering the competent 
conformation in incompetent but structured dimers, tetramers, and 
octamers. This system, which is compatible with a discrete multi-funnel 
energy landscape, affords a switch that provides a reversible mechanism of 
control of catalytic activity unique in nature. 
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1. EXPERIMENTAL PROCEDURES 
1.1. Protein production and purification — The gene coding for selecase (110 residues, 13.1KDa; 
“uncharacterized protein MJ1213” according to UniProt (UP) sequence database access code Q58610) was 
amplified from Methanocaldococcus jannaschii genomic DNA. It was cloned at BamHI and HindIII restriction 
sites into vector pPROEX-HTa (Invitrogen), which confers resistance towards ampicillin and attaches an N-
terminal hexahistidine-tag (His6-tag) followed by a tobacco etch virus (TEV) proteinase recognition site among 
other residues (M-S-Y-Y-H-H-H-H-H-H-D-Y-D-I-P-T-T-E-N-L-Y-F-Q-!-G-A-M-D-P; the arrow shows the 
TEV proteinase cleavage site). This gave rise to tagged 16.5-KDa selecase. The gene was also cloned using NdeI 
and XhoI restriction sites into vector pCRI7 (modified from pET28a vector; Novagen), which confers resistance 
towards kanamycin and does not attach extra residues (13.1-KDa selecase). Single-residue point mutants were 
generated using the QuikChange Site-Directed Mutagenesis Kit (Stratagene) according to the manufacturer’s 
instructions using either the pPROEX-HTa (point mutant E70A) or the pCRI7 (point mutants R36W, I100F, I103E, 
and H107F) constructs as template. Multiple-residue point mutants (I100F+H107F, I103E+H107F, I100F+I103E+H107F) 
were similarly generated starting from single-residue mutants. Deletion variants without the last four (slc"C4; 
lacking H107-Q-K-K110; superscripted residue numbering of selecase according to UP 58610) and eight residues 
(slc"C8; lacking I103-N-K-L-H-Q-K-K110) were prepared with the pCRI7 construct as template. Synthetic genes 
encoding two selecase orthologs from Methanotorris igneus (114 residues, 13.6KDa; UP F6BCT9) and 
Methanocaldococcus fervens (118 residues, 14.1KDa; UP C7P7R3) were purchased from GeneArt (Invitrogen) 
and cloned into vector pCRI7 as described above. All constructs were verified by DNA sequencing. Proteins were 
produced by heterologous overexpression in Escherichia coli BL21 (DE3) cells, which were grown at 37°C in 
Luria Bertani medium supplemented with either 100#g/ml ampicillin (pPROEX-HTa vector) or 30#g/ml 
kanamycin (pCRI7 vector). Cultures were induced at an A600 of 0.8 with 0.2-1mM isopropyl-$-D-
thiogalactopyranoside and incubated either for 5h at 37°C or overnight at 18°C.  
Purification and processing of 16.5-KDa selecase and its E70A mutant was performed as follows. After 
centrifugation at 7,000xg for 30min at 4°C, the pellet was washed twice with buffer A (50mM Tris-HCl, 500mM 
NaCl, pH8.0), resuspended in the same buffer plus 10mM imidazole, and supplemented with EDTA-free protease 
inhibitor cocktail tablets and DNase I (both Roche Diagnostics). Cells were lysed using a cell disrupter (Constant 
Systems) at a pressure of 1.35Kbar, and the cell debris was removed by centrifugation at 50,000xg for 1h at 4°C. 
The supernatant was filtered (0.22µm pore size; Millipore), loaded onto a HiTrap Chelating HP column (GE 
Healthcare) charged with nickel sulfate, and the fusion protein was eluted using a gradient of buffer A plus 10-
500mM imidazole. Subsequently, the sample was dialyzed overnight at 20°C against buffer B (50mM Tris-HCl, 
250mM NaCl, 1mM dithiothreitol, pH8.0) in the presence of His6-tagged TEV proteinase at a proteinase:sample 
molar ratio of 1:200. This cleavage left peptide G-A-M-D-P at the N-terminus of the protein (13.6-KDa selecase). 
The digested sample was passed several times through nickel-nitrilotriacetic acid resin (Invitrogen) previously 
equilibrated with buffer A plus 10mM imidazole to remove His6-containing molecules. The flow-through was 
collected, concentrated by ultrafiltration, and further purified by size-exclusion chromatography (SEC) on a 
HiLoad 26/60 Superdex 75 column (GE Healthcare) previously equilibrated with buffer C (20mM Tris-HCl, 
500mM NaCl, pH7.5). Some preparations of 16.5-KDa selecase underwent spontaneous autolytic cleavage in the 
N-terminal fusion region during purification (Suppl. Fig. 1b), thus giving rise to a variant that contained seven 
extra N-terminal residues (F-Q-G-A-M-D-P; 13.8-KDa selecase). 
Untagged wild-type 13.1-KDa selecase, its single- and multiple-residue point mutants, the C-terminal 
deletion variant slc"C4, and the M. igneus and M. fervens orthologs were purified as follows. After centrifugation 
at 7,000xg for 30min at 4°C, the pellet was washed twice with buffer A and resuspended in the same buffer 
supplemented with EDTA-free protease inhibitor cocktail tablets and DNase I. Cells were lyzed at 4ºC using a 
cell disrupter as described above, and the cell debris was removed by centrifugation at 50,000xg for 1h at 4°C. 
The supernatant was incubated for 1h either at 65°C (wild type) or 50ºC (mutants, deletion variants and 
orthologs), and the precipitate was removed by centrifugation at 50,000xg for 1h at 4°C. The supernatant was 
filtered (0.22µm pore size) and dialyzed overnight at room temperature against buffer D (20mM Tris-HCl, 
150mM NaCl, pH7.0). The protein was subsequently purified by cation exchange chromatography using a 
HiLoad 16/10 SP Sepharose HP column (GE Healthcare), and by SEC on a HiLoad 26/60 Superdex 75 column 
(GE Healthcare), previously equilibrated with buffer C.  
Protein identity and purity were assessed by 15% Tricine-SDS-PAGE stained with Coomassie blue and 
mass spectrometry (MS). Ultrafiltration steps were performed with Vivaspin 15 and Vivaspin 500 filter devices 
of 5-KDa cut-off (Sartorius Stedim Biotech). Approximate protein concentration was determined by measuring 
A280 in a spectrophotometer (NanoDrop) and the calculated absorption coefficient, !0.1% = 0.45, except for mutant 
R36W (!0.1% = 0.87) and the ortholog from M. fervens (!0.1% = 0.53). N-terminal sequencing through Edman 
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degradation, peptide-mass fingerprinting of tryptic protein digests, and MS analyses were carried out at the 
Proteomics Facilities of Centro de Investigaciones Biológicas (CIB; Madrid, Spain) and Vall d’Hebron Institute 
of Oncology (Barcelona, Spain).   
1.2. Proteolytic and inhibitor assays – Proteolytic activities were assayed at 37°C in buffer E (50mM 
MES, 150mM NaCl, pH5.5), buffer F (50mM HEPES, 150mM NaCl, pH7.5) or buffer G (50mM CHES, 150mM 
NaCl, pH9.5) at 20#M final protein concentration unless otherwise stated. To provide reproducible and 
comparable activity, selecase was subjected to four consecutive overnight dialysis steps at 4°C against buffer C 
plus, respectively, 10mM 1,10-phenantroline; 1mM 1,10-phenantroline; 1mM ZnCl2; and 10µM ZnCl2. 
Proteolytic activity against the fluorescein conjugates BODIPY FL casein, DQ gelatin, and DQ bovine 
serum albumin (all from Invitrogen) was measured according to the manufacturer’s instructions using a 
microplate fluorimeter (FLx800, BioTek or Infinite M200, Tecan). Assays with natural protein substrates (at 
0.5mg/ml; all from Sigma) included bovine plasma fibronectin, bovine muscle actin, human plasma fibrinogen, 
cold-water fish-skin gelatin, bovine milk casein, and bovine milk %-casein. In general, reactions were carried out 
overnight in buffer F at 37°C, 65°C, and 80°C at an enzyme:substrate ratio of 1:5 (w/w) for the first two 
substrates and 1:10 (w/w) for the others. Cleavage was assessed by 15% Tricine-SDS-PAGE stained with 
Coomassie blue. For the particular case of cleavage of bovine milk %-casein depicted in Suppl. Fig. 1a, the 
substrate was incubated with 13.6-KDa selecase (at 25µg/ml; peptidase:substrate molar ratio 1:20; identical 
results for 13.1-KDa selecase, data not shown). PageRuler Plus Prestained Protein Ladder (Fermentas) was used 
as molecular mass standard. Activity from contaminating TEV peptidase, which is a cysteine peptidase, was ruled 
out as this protease did not react with %-casein in a control assay (data not shown) and was insensitive to general 
metallopeptidase (MP) inhibitors, which however completely abolished cleavage (see below and Suppl. Table 1). 
In addition, proteolytic activity was assayed in a zymogram of bovine milk %-casein (Suppl. Fig. 1b). Samples 
were prepared without reducing or boiling. Following electrophoresis on 12.5% Glycine-SDS-PAGE, SDS was 
removed from the gel with two washes in 2.5% (w/v) Triton X-100 for 20min. The zymogram was incubated for 
48h at 37°C in buffer F and subsequently stained with Coomassie blue. 
Peptidolytic activity was further tested on ten fluorogenic peptide substrates of sequence: Abz-K-D-E-S-Y-
R-K(dnp) (Abz, aminobenzoyl; dnp, 2,4-dinitrophenylamino); Abz-T-V-L-E-R-S-K(dnp); Abz-D-Y-V-A-S-E-
K(dnp); Abz-Y-G-K-R-V-F-K(dnp); Abz-V-K-F-Y-D-I-K(dnp); Dabcyl-L-A-R-V-E-Edans (Dabcyl, p-
dimethyl(aminophenyl)azobenzoate; Edans, 2-aminoethylamino-1-naphthalene sulfonate); Abz-G-I-V-R-A-
K(dnp); Mca-P-L-G-L-Dap(dnp)-A-R-NH2 (Mca, 7-methoxycoumarin-4-acetyl; Dap, L-diaminopropionyl); Mca-
R-P-K-R-V-E-Nva-W-R-K(dnp)-NH2 (Nva, norvaline); and Dnp-P-L-G-L-W-A-(D)R-NH2 (all from Bachem; see 
Ref. [1] for details on the first six substrates). Further activity assays were performed with the fluorogenic peptide 
substrate Abz-E-L-A-Y-F-Y-P-E-K(dnp) (peptide CCS; purchased from GL Biochem Ltd), which mimics the 
cleavage site of bovine milk %s1-casein (Suppl. Fig. 1c; see also section 2). Reactions were monitored in a 
microplate fluorimeter (Infinite M200, Tecan) at enzyme:substrate molar ratios of 1:0.25, 1:0.5, 1:1.25, and 
1:6.25. Kinetic parameters of peptide CCS cleavage were obtained (kcat = 4±0.2 x 10-4s-1; Km = 3±0.3µM; kcat/Km 
= 133M-1s-1) using the substrate in buffer F at 37°C according to the Michaelis-Menten equation implemented in 
the SIGMAPLOT v.10.0 program. Peptide CCS was also used to determine the optimal pH for activity (Suppl. 
Fig. 1d) in buffer 150mM NaCl with 50mM MES for pH5.5-6.5; 50mM HEPES for pH7.0-8.0; and 50mM CHES 
for pH8.5-9.5, respectively. Carboxypeptidase activity against the chromogenic substrates N-(3-[2-
furyl]acryloyl)-F-F-OH (Bachem), N-(3-[2-furyl]acryloyl)-G-L-A-OH (Bachem), and N-(3-[2-furyl]acryloyl)-L-
G-P-A-OH (Sigma) was tested using a microplate spectrophotometer (PowerWave XS, BioTek) at 
enzyme:substrate molar ratios of 1:5 and 1:25. Aminopeptidase activity was assayed with fluorogenic substrates 
F-Amc (Amc, 7-amino-4-methylcoumarin), (H)T-Amc, and Y-Amc (all from Bachem), and with the p-
nitroanilide (pNA) derivatives of a representative set of natural L-amino acids and peptides (from Bachem): A-
pNA, M-pNA, L-pNA, K-pNA, V-pNA, (H)I-pNA, (H)G-pNA, N-acetyl-F-pNA, A-A-pNA, N-
benzyloxycarbonyl-V-G-R-pNA, N(%)-benzoyl-I-E-G-R-pNA, and N-succinyl-A-A-P-F-pNA. Reactions were 
monitored in a microplate fluorimeter (FLx800, BioTek) or a PowerWave XS spectrophotometer (BioTek) at 
enzyme:substrate molar ratios of 1:125 and 1:250.  
For inhibition assays, selecase (at 2µM in buffer F) was incubated for 30min with inhibitors of different 
protease classes, and the remaining proteolytic activity on peptide CCS was measured at 37°C (Suppl. Table 1). 
Activity of metal-substituted selecase variants was assayed using the latter substrate and protein (at 20#M) 
subjected to, first, metal removal through sequential dialysis against 10mM and 1mM 1,10-phenanthroline and, 
next, sequential dialysis against 1mM and 10µM of zinc, cobalt, magnesium, manganese, calcium, cadmium, 
copper, and nickel chloride or sulfate salts (Suppl. Table 2). 
1.3. Concentration dependence of proteolytic activity — Proteolytic activity against peptide CCS (at 
10µM) based on the initial rate of reaction was determined as described in section 1.2 for 13.1-KDa selecase at 
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0.025, 0.050, 0.075, 0.15, 0.25, 0.35, 0.50, 1.0, 5.0, 10, 20, and 50mg/ml in buffers C and H (20mM Tris-HCl, 
150mM NaCl, pH7.5; see Fig. 1a). Aprotinin (from Sigma), which was used as an internal molecular-mass 
standard in SEC (see next section), did not interfere with catalytic activity (data not shown). TEV proteinase 
mutant S219V, produced and purified according to [2], was used as a control for a normally behaving peptidase in 
a concentration-dependent activity assay at 0.025, 0.050, 0.075, 0.15, 0.50, 1.0, 5.0, and 10mg/ml in buffer I 
(20mM Tris-HCl, 150mM NaCl, 10% glycerol, 1mM dithiothreitol, pH8.0) at 30°C against the fluorogenic 
peptide substrate Abz-E-N-L-Y-F-Q-E-G-K(dnp) (GL Biochem Ltd) (also at 10µM; see Fig. 1a), which was 
chosen because it was reported to be cleaved with a similar efficiency to that of selecase with peptide CCS [3]. 
The activity of this TEV proteinase was adjusted to a hyperbolic curve with program SIGMAPLOT (Fig. 1a). The 
kinetic parameters were kcat = 0.014±10-3s-1; Km = 94±22µM; kcat/Km = 150M-1s-1 (compare with values of section 
1.2 for selecase; see also [3] for other TEV variants and substrates). In addition, a sample of selecase at 5.0mg/ml, 
which was only residually active, was diluted to 0.025mg/ml in buffer and analyzed for proteolytic activity 
against peptide CCS. This sample revealed activity equivalent to that of selecase at 0.025mg/ml that had not been 
concentrated before (data not shown), thus showing that concentration-dependent inactivation was reversible. 
Finally, selecase single- and multiple-residue mutants, deletion variant slc"C4, and the orthologs from M. igneus 
and M. fervens were assayed for activity as described above for peptide CCS at 0.25, 0.50, 2.5 and 5.0mg/ml in 
buffer H. 
1.4. Size-exclusion chromatography and multi-angle laser light scattering  — 13.1-KDa selecase at 0.15, 
0.50, 1.0, 5.0, 10, 25, and 50mg/ml in buffers C and H plus 30, 75, 165, 180, 180, 180, and 180µg of aprotinin, 
respectively, as internal calibrator were analyzed at room temperature by SEC on a Superdex 75 10/300 GL 
column (GE Healthcare) connected to an ÄKTA Purifier System (GE Healthcare) and previously equilibrated 
with the same buffer (Suppl. Fig. 2a; curve at 25mg/ml omitted for clarity). Passage through this chromatographic 
column led to dilution of the samples. Equivalent results were obtained with 13.6-KDa selecase (data not shown). 
The column was calibrated with the following protein standards: conalbumin (75KDa; 9.99ml), ovalbumin 
(44KDa; 10.76ml), carbonic anhydrase (29KDa; 11.85ml), ribonuclease A (13.7KDa; 13.33ml), and aprotinin 
(6.5KDa; 15.18ml). The theoretical migration volumes of monomeric, dimeric and tetrameric selecase were 
calculated according to the elution volumes of the protein standards and corrected according to the hydrodynamic 
parameters calculated with the HYDRAPRO program [4] using the coordinates of the respective structures (see 
section 1.10). The theoretical reference value for an octamer was derived from the calibration curve. In addition, a 
sample of selecase at 25mg/ml was loaded onto this column previously equilibrated with buffer H, collected at 
0.3mg/ml, and subsequently re-loaded at this protein concentration onto the same column. This assay revealed a 
chromatogram comparable to a protein sample at 0.3mg/ml that had not been concentrated before (data not 
shown), thus revealing that concentration-dependent oligomerization is reversible. Furthermore, nickel-selecase 
(see section 1.2) was concentrated to 11mg/ml in the presence of peptide A-Y-F-Y-P (purchased from GL 
Biochem Ltd.) at 1mM in buffer H and was analyzed by SEC on a Superdex 75 10/300 GL column previously 
equilibrated with the same buffer and using 180µg of aprotinin as internal calibrator. The chromatogram mainly 
corresponded to a monomeric species (Suppl. Fig. 2a). Finally, selecase single- and multiple-residue mutants, 
deletion variant slc"C4, and the orthologs from M. igneus and M. fervens were likewise analyzed by SEC at 
0.50mg/ml and 5.0mg/ml in buffer H (Suppl. Fig. 5a,b). 
13.1-KDa selecase at 0.15, 0.30, 0.63, 1.2, 4.5, 8.5, 22, 46, and 65mg/ml in buffer H was analyzed at room 
temperature by SEC (same column as above but connected to a Waters Alliance apparatus) coupled to a multi-
angle laser light scattering (MALLS) device connected to DAWN HELEOS II and Optilab T-rEX (refractometer 
with EXtended range) detectors (from Wyatt Technology). SEC-MALLS was similarly performed for nickel-
selecase at 0.25, 1.0, 10, and 50mg/ml. Data were processed with ASTRA 6 software for direct determination of 
the absolute molar mass of samples and the differential refractive index (dRI) (Fig. 1b and Suppl. Fig. 2b). The 
experiments were performed at UVHCI-EMBL (Grenoble, France). 
1.5. Analytical ultracentrifugation — Analytical ultracentrifugation (AUC) of 13.1-KDa selecase at 0.03, 
0.10, 0.30, 0.90, 3.0, 9.0, and 18mg/ml in buffer H was carried out at 20°C using a Beckman Coulter Optima XL-
I analytical ultracentrifuge with an An50 Ti 8-hole rotor at the Analytical Ultracentrifugation and Light Scattering 
Facility of CIB (Madrid, Spain). AUC was similarly performed for nickel-selecase at 0.03, 0.10, 0.30, 0.90, and 
3.0mg/ml. Sedimentation velocity experiments were performed at 48,000rpm, with buffer density "=1.00499g/ml 
and viscosity #=0.010214Pose (Vbar = 0.7655ml/g), and the data were analyzed using program SEDFIT v14.1 ([5]; 
Suppl. Table 3). Sedimentation equilibrium data were acquired at 11,000, 16,000, and 20,000rpm and analyzed 
using HeteroAnalysis v1.1.44 software ([6]; Suppl. Table 3) 
1.6. Chemical crosslinking experiments — 13.1-KDa selecase at 0.15, 0.50, 2.0, 5.0, 10, 20, and 40mg/ml 
in buffer F was incubated with a collection of crosslinking reagents, namely glutaraldehyde, formaldehyde, 1-
ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC; exceptionally in buffer E), dimethyl 
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adipimidate (DMA), dimethyl pimelimidate (DMP), and bis(sulfosuccinimidyl)suberate (BS3) (the first two from 
Sigma, the others from Pierce) at different protein:crosslinker ratios (1-to-20-fold molar excess of crosslinker), at 
different temperatures (4°C, room temperature, 37°C, and 50°C), and for different time periods (10min-12h). The 
crosslinking solutions were always prepared immediately before use. The reactions were quenched with 
denaturing loading buffer and analyzed by 15% Tricine-SDS-PAGE stained with Coomassie blue.  
1.7. Circular dichroism spectroscopy — 13.1-KDa selecase containing either zinc or nickel in the active 
site (see section 1.2) were prepared at 0.10mg/ml and 0.50mg/ml in buffer H for far-UV (180-260nm) and near-
UV (250-330nm) circular dichroism spectroscopy. Measurements were carried out in a Jasco J-815 spectrometer 
at 20°C using 1-mm and 1-cm path length cells for far-UV and near-UV, respectively. The obtained spectra were 
analyzed with program Spectra Analysis v2.09.03. 
1.8. Small-angle X-ray scattering — 13.1-KDa selecase at 0.15, 0.30, 0.63, 1.2, 1.9, 4.5, 8.5, 15, 22, 46, 
and 65mg/ml in buffer H was analyzed by small-angle X-ray scattering (SAXS). SAXS data were collected at 
20°C on a Pilatus 1M pixel detector (from Dectris) at beam line BM29 [7] of the European Synchrotron Radiation 
Facility (ESRF, Grenoble, France) within the Block Allocation Group “BAG Barcelona.” SAXS was similarly 
performed with nickel-selecase at 0.15, 0.25, 0.50, 1.0, 2.0, 5.0, 10, 25, and 50mg/ml. Data were recorded using a 
robot sample changer at a sample-to-detector distance of 2.85m, thus covering the range of momentum transfer 
0.0036<s<0.501Å&1 (s = 4'sin(/), where 2( is the scattering angle and ) = 0.991Å is the X-ray wavelength). To 
assess radiation damage, ten successive one-second exposures were compared and no significant changes were 
observed (data not shown). Buffer subtraction was performed using standard protocols with program PRIMUS [8]. 
The forward scattering I(0), as well as the radius of gyration (Rg), were calculated using the Guinier 
approximation assuming that, at very small angles (s<1.3/Rg), the intensity, I(s), can be represented as 
I(s)=I(0)*exp(&(sRg)2/3). The pair-distance distribution function, P(r), from which the maximum particle 
dimensions (Dmax) were estimated, was computed with program GNOM [9]. See Suppl. Table 4. 
Single Value Decomposition (SVD) analysis as implemented in program MATLAB (MathWorks, Natick, 
Mass.) was used to assess the number of species required to describe the SAXS dataset of selecase at the distinct 
concentrations. The eigenvalues, the shape of the eigenvectors, and the capacity to describe the complete dataset 
with an increasing amount of species were used as criteria to assess the number of species present. Low-
concentration curves (0.15, 0.30, and 0.63mg/ml) were univocally identified as corresponding to a monomer-
dimer equilibrium with program OLIGOMER [10] using the crystal structures reported in the present work (slc1 
and slc2; see sections 1.9 and 1.10). Computation of the theoretical scattering profiles from the crystallographic 
models was performed with program CRYSOL [11]. 
1.9. Crystallization and data collection — Crystallization screenings were performed at the IBMB/IRB 
Crystallography Platform (PAC, Barcelona) by the sitting-drop vapor diffusion method using 96x2-well MRC 
plates (Innovadyne). A TECAN Freedom EVO robot was used to prepare reservoir solutions, and a Cartesian 
Microsys 4000 XL (Genomic Solutions) robot or a Phoenix/RE (Art Robbins) robot was used for nanodrop 
dispensing. Crystallization plates were stored in Bruker steady-temperature crystal farms at 4ºC or 20°C. 
Successful hits were scaled up to the microliter range with 24-well Cryschem crystallization dishes (Hampton 
Research) whenever possible. Both wild-type selecase variants assayed (13.1-KDa- and 13.6-KDa-selecase) 
behaved equivalently in crystallization studies. Dimeric wild-type selecase (slc2) and tetrameric wild-type 
selecase (slc4) crystallized from protein solutions at 54mg/ml and 9.0-100mg/ml in buffer C, respectively. Best 
crystals of slc2 were tetragonal and appeared at 20°C in equivolumetric drops containing protein solution and 
100mM sodium cacodylate, 30% (v/v) 2-methyl-2,4-pentanediol, 3% (w/v) polyethylene glycol 8,000, pH6.5 as 
reservoir solution. Crystals of slc4 were hexagonal and appeared at 16-20°C in equivolumetric drops containing 
protein solution and several reservoir solutions, among them 100mM Bis-Tris propane, 200mM sodium citrate, 
18-24% (w/v) polyethylene glycol 3,350, pH7.0-9.0 as the best. Monomeric wild-type slc1 yielded orthorhombic 
crystals at 20°C in equivolumetric drops containing nickel-selecase protein solution (obtained as mentioned in 
section 1.2; see also section 2) at 11mg/ml in buffer C with pentapeptide A-Y-F-Y-P (GL Biochem Ltd.) at 5mM, 
and 100mM Tris-HCl, 200mM sodium acetate, 30% (w/v) polyethylene glycol 4,000, pH8.5; or 100mM Tris-
HCl, 30% (w/v) polyethylene glycol 3,500, pH8.5 as reservoir solution. Monoclinic crystals of dimeric selecase 
mutant R36W (slc2’) were serendipitously obtained directly from protein solution at 5.0mg/ml in buffer H stored at 
4ºC for one month. Crystals of orthorhombic dimeric selecase mutant I100F+H107F (slc2’’) were obtained at 5.0-
11mg/ml in equivolumetric drops with several different reservoir solutions, both at 4ºC and 20ºC (all crystals 
tested corresponded to the same crystal form). The best conditions contained 100mM sodium cacodylate, 1M 
sodium acetate trihydrate, pH6.5 as reservoir solution. All crystals were cryo-protected by rapid passage through 
drops containing increasing concentrations of glycerol (up to 20% (v/v)).  
Complete diffraction datasets were collected at 100K from liquid-N2 flash cryo-cooled crystals (Oxford 
Cryosystems 700 series cryostream) on a MarCCD detector (from Marresearch) at beam line ID23-2 of ESRF 
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(Grenoble, France) within the Block Allocation Group “BAG Barcelona” (slc1, slc2’ and slc4) or on a Pilatus 6M 
pixel detector (from Dectris) at beam line XALOC of synchrotron ALBA (Barcelona, Spain; slc2 and slc2’’). All 
crystal types contained one molecule per asymmetric unit except the mutant ones, which harbored four (slc2’; two 
dimers) and two molecules (slc2’’; one dimer). Diffraction data were integrated, scaled, merged, and reduced with 
programs XDS [12] and XSCALE [13] or SCALA [14] within the CCP4 suite of programs [15] (see Suppl. Table 5 for 
data processing statistics). 
1.10. Structure solution and refinement — The structure of tetragonal slc2 was the first to be solved, by 
likelihood-scoring molecular replacement using program PHASER [16] and a searching model obtained by 
trimming the side chains of proabylysin (PDB 4JIX; [17]) with CHAINSAW [18] according to a sequence alignment 
performed with MULTALIN [19]. The final refined solution corresponded to Euler angles %=165.1º, $=83.7º, 
+=25.8º and fractional cell coordinates x=0.52, y=0.18, z=-0.14 and had initial Z-scores for the rotation and 
translation functions of 5.7 and 12.5, respectively. Subsequent model building with the COOT program [20] 
alternated with crystallographic refinement with PHENIX [21] and BUSTER/TNT [22], which included TLS 
refinement, until the final refined slc2 model was obtained. The latter consisted of residues D3-K110, one zinc ion, 
three glycerol molecules, and 30 solvent molecules.  
The structure of hexagonal slc4 was solved thereafter with PHASER and the coordinates of the protein part 
only of tetragonal slc2 fragment D3-K109 excepting loop Y76-I81. The final refined solution corresponded to Euler 
angles %=10.2º, $=27.5º, +=154.3º and fractional cell coordinates x=0.46, y=0.59, z=0.17, and had initial Z-scores 
for the rotation and translation functions of 3.5 and 8.3, respectively. Visual inspection of the rotated and 
translated molecule with COOT revealed clashes and regions lying outside of the Fourier map for the C-terminal 
part of the model, so the first refinement step was performed with fragment D3-K75 only. This was followed by a 
density modification and model extension step with the AUTOBUILD protocol of PHENIX [23], which produced 
an improved Fourier map. Thereafter, model completion and refinement proceeded as for slc2. The final model of 
slc4 comprised residues K2-K109, one zinc cation, one tentative sodium cation, four glycerol molecules, and one 
solvent molecule. The sodium ion does not play an essential structural or functional role and its—tentative—
presence may be attributed to the crystallization conditions. 
The structure of orthorhombic slc1 was also solved with PHASER using protein fragment D3-K75 of slc2 as 
a searching model. The final refined solution corresponded to Euler angles %=266.3º, $=125.9º, +=134.1º and 
fractional cell coordinates x=-0.32, y=0.35, z=0.31, and had initial Z-scores for the rotation and translation 
functions of 6.6 and 7.9, respectively. A Fourier map calculated with the appropriately rotated and translated 
model was then subjected to density modification and model extension with both ARP/wARP [24] and the 
AUTOBUILD routine of PHENIX. Models were then built based on both resulting Fourier maps. Subsequently, 
model completion and refinement proceeded as for slc2 and slc4. The pentapeptide used to maintain selecase in its 
monomeric quaternary structure (see sections 1.9 and 2) was apparently bound with very low occupancy, so in the 
final Fourier map the corresponding region was conservatively interpreted as housing solvent molecules. 
Therefore, the final model of slc1 comprised protein residues M1-K109, one nickel cation mimicking the active-site 
zinc, one glycerol molecule, and 58 solvent molecules. 
The monoclinic structure of dimeric protein variant slc2’ (mutant R36W) was solved by likelihood-scoring 
molecular replacement with slc2 fragment D3-Y76 using program MOLREP [25] taking advantage of a local two-
fold axis revealed by a previously calculated self rotation function at angles (=170º, ,=0º, -=180º, respectively 
(peak height 78% of origin peak). A Fourier map calculated with the four appropriately rotated and translated 
polypeptide chains in the asymmetric unit was then subjected to density modification and model extension with 
the AUTOBUILD routine of PHENIX. Subsequently, model completion and refinement proceeded as mentioned 
above. The final model of slc2’ contained residues K2-K109 of molecule A and M1-K109 of molecule B, 
corresponding to one dimer, and R4-K109 of molecule C and D3-K109 of molecule D, the latter two corresponding 
to the second dimer. In addition, four catalytic zinc ions, four glycerol molecules, one tentative chloride anion, 
and 149 solvent molecules completed the model. The chloride ion does not play an essential structural or 
functional role and its—tentative—presence may be attributed to the crystallization conditions. Dimer AB was 
better defined by the final Fourier map than dimer CD, as revealed by the respective average thermal 
displacement parameters (A/B: 47.0/50.0Å2; C/D: 81.4/71.5Å2). Superposition of both dimers with program 
COOT revealed they are essentially identical, with a core rmsd of 0.43Å, so presentation of results and discussion 
will center on dimer AB if not otherwise stated. 
Finally, the orthorhombic dimeric structure of slc2’’ (mutant I100F+H107F) was likewise solved with 
PHASER using protein fragment D3-K75 of slc2 as a searching model. The two final refined solutions 
corresponded to Euler angles %=83.8º, $=63.9º, +=135.9º and %=191.4º, $=128.1º, +=319.7º, and to fractional cell 
coordinates x=0.08, y=0.01, z=0.98 and x=0.72, y=0.75, z=0.29, respectively, and had initial Z-scores for the 
rotation/translation functions of 5.3/4.7 and 8.2/7.6, respectively. A Fourier map calculated with the appropriately 
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rotated and translated models was then subjected to density modification and model extension with ARP/wARP. 
Thereafter, model completion and refinement proceeded as mentioned above. The final model of slc2’’ comprised 
residues M1-Q108 of both molecules A and B, two zinc cations, five acetate anions, one glycerol, and 251 solvent 
molecules. Superposition of both monomers with program COOT revealed they are essentially identical, with a 
core rmsd of 0.37Å. 
Suppl. Table 5 provides a summary of the final model refinement processes. 
1.11. Bioinformatics — Figures were prepared with the CHIMERA program [26]. Close contacts (<4Å) 
were determined with CNS [27]. Interaction surfaces and theoretic values of the standard Gibbs free energy ("G) 
were computed with the PISA program [28] at http://www.ebi.ac.uk/pdbe/pisa with default parameters. Quaternary 
analyses were likewise performed with PISA. Structural superpositions were performed with the SSM routine [29] 
within COOT. Surface complementarity was computed with program SC [30] within CCP4 with default parameters 
and protein residues only. Local configurational frustration was analyzed with the FRUSTRATROMETER [31] at 
http://lfp.qb.fcen.uba.ar/embnet. Inter-domain flexibility was determined with HINGEPROT [32] with parameters 
GNM=20 and ANM=36 at http://www.prc.boun.edu.tr/appserv/prc/hingeprot/index.html. Model validation was 
performed with MOLPROBITY [33], COOT, the WHATCHECK routine of WHATIF [34], and the wwPDB 
Validation Server at http://wwpdb-validation.wwpdb.org/validservice. Secondary structure prediction was 
performed with JPRED3 [35]. The final coordinates of slc1, slc2, slc2’, slc2’’, and slc4 have been deposited with the 
PDB (access codes 4QHF, 4QHG, 4QHH, 4QHI, and 4QHJ, respectively). 
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2. SUPPLEMENTAL RESULTS AND DISCUSSION 
Overall, four N-terminally differing variants of wild-type selecase were obtained (see section 1.1): 16.5-
KDa selecase, which contained 28 extra residues including a His6-tag and a TEV proteinase recognition sequence 
preceding the first methionine of the natural protein; 13.8-KDa selecase, which resulted from occasional autolytic 
cleavage of 16.5-KDa selecase and had the extra N-terminal residues F-Q-G-A-M-D-P (see below); 13.6-KDa 
selecase, which was produced by TEV proteinase processing of 16.5-KDa selecase and had extra residues G-A-
M-D-P; and the natural 13.1-KDa selecase, which did not have any additional residues. All variants showed 
equivalent proteolytic activity and susceptibility towards inhibitors, as well as crystallizability (here, only 13.1-
KDa and 13.6-KDa selecase variants were tested). Cleavage activity for selecase was only detected with bovine 
milk %s1-casein, at bond Y159-F160 (see UP P02662) within segment E-L-A-Y-!-F-Y-P (Suppl. Fig. 1a,b), as 
determined by N-terminal sequencing. This segment is close to an epitope responsible for allergenicity (N154-F168) 
of this casein chain, and proteolysis herein decreased immuno-reactivity of this protein [36]. This points to a 
potential biotechnological application of selecase in the treatment of alimentary casein and in other casein-related 
applications. Moreover, 16.5-KDa selecase underwent spontaneous autolysis within the TEV proteinase 
recognition sequence in some preparations at a site (E-N-L-Y-!-F-Q-G) that is similar to the casein cleavage site. 
However, while a fluorogenic peptide mimicking the casein cleavage site (peptide CCS) was likewise efficiently 
cleaved (kcat/Km = 133M-1s-1), preferentially at pH values close to neutrality (see section 1.2 and Suppl. Fig. 1c,d), 
fluorogenic peptides encompassing two sequences recognized by TEV proteinase (E-N-L-Y-F-Q-S and E-N-L-Y-
F-Q-E) were not cleaved by selecase, which indicates that autolytic cleavage occurs only slowly and at high 
concentrations. We conclude that selecase is a selective and specific caseinolytic endopeptidase. 
Selecase active-site mutant E70A, which ablated the catalytically essential general base/acid glutamate of 
the zinc-binding signature (H-E-X-X-H) that is characteristic of most MPs [37], was inactive against casein and 
peptide CCS (Suppl. Fig. 1a-c). General MP inhibitors (EDTA, 1,10-phenanthroline and excess zinc; see Suppl. 
Fig. 1a,b and Suppl. Table 1) and some matrix metalloproteinase/ADAM inhibitors (batimastat and MMP 
inhibitor III were the best) abolished selecase activity (Suppl. Table 1). Metals other than zinc did not restore 
activity of metal-depleted apo-selecase with the exception of cobalt, which enhanced its activity (Suppl. Table 2) 
as reported for other MPs such as carboxypeptidase A, thermolysin, and astacin [38]. In particular, nickel-selecase 
was inactive. These studies show that selecase is a MP. 
Selecase was characterized for concentration-dependent oligomerization behavior in solution using a 
battery of complementary biophysical techniques: SEC (see section 1.4), SEC-MALLS (section 1.4), AUC 
(section 1.5), chemical crosslinking followed by SDS-PAGE (section 1.6), circular dichroism spectroscopy 
(section 1.7), and SAXS (section 1.8): 
The peak pattern of selecase analyzed by both calibrated SEC and SEC-MALLS moved towards smaller 
elution volumes with increasing protein concentration, indicating ordered protein oligomerization but not 
indiscriminate aggregation or precipitation (Suppl. Fig. 2a,b). In SEC, only concentrations at or below ~0.2mg/ml 
contained essentially monomeric selecase (Suppl. Fig. 2a). In SEC-MALLS, the calculated absolute mass of the 
different peaks revealed two main average values of ~25KDa and ~80KDa, which would be consistent with 
dimeric and octameric oligomers, respectively. However, the substantial difference in the elution volumes of 
protein at 0.15mg/ml and 1.2mg/ml indicated the presence of additional species such as monomeric selecase at 
lower concentrations. In addition, the amplitude of the peaks at higher concentrations suggested the presence of 
tetramers. SEC-MALLS experiments performed in parallel with nickel-selecase showed essentially the same 
results (data not shown). 
AUC sedimentation velocity and sedimentation equilibrium analyses determined the population of 
species and average mass at the different protein concentrations, with predominance of monomers at 0-0.3mg/ml, 
dimers at 0.3-2mg/ml, tetramers at 2-6mg/ml, and octamers at >6mg/ml. Sedimentation velocity experiments 
performed using zinc-selecase at 0.03-0.1mg/ml showed a majority species with sedimentation coefficient of 
1.5S. This value was initially assigned by the software to dimeric selecase. However, in zinc-containing proteins 
this value would correspond to monomeric selecase as previously reported [5, 39]. This was further confirmed by 
the use of nickel-selecase at this same concentration range, which resulted in a coefficient of 1.3S that 
unequivocally corresponds to a monomer. As in the sedimentation velocity experiments, the use of nickel-
selecase was more conclusive in the equilibrium velocity experiments than zinc-selecase in showing the 
prevalence of monomeric protein at low concentrations, with average masses of 14.6KDa and 15.4KDa at 
0.1mg/ml and 0.3mg/ml, respectively (see also Fig. 1c and Suppl. Table 3).  
Overall, crosslinking experiments followed by SDS-PAGE revealed the presence of monomers, dimers, 
monomers linked to dimers, and tetramers. Formaldehyde, EDC, DMA, DMP, and BS3 showed the presence of 
monomers and dimers in reactions with protein concentration .0.5mg/ml. Formaldehyde and BS3 further showed 
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the formation of a monomer linked with a dimer, and of a tetramer (see Suppl. Fig. 2c). Unfortunately, selecase 
tended to precipitate at high protein and crosslinker concentrations (20mg/ml and 5-fold molar excess, 
respectively), which prevented detection of higher oligomeric species than tetramers and the overall quantitative 
assessment of concentration-dependent oligomerization by this technique. We attribute this precipitation to the 
high number of lysines in selecase (17 out of 110 residues), which are targeted by crosslinking reagents. 
Circular dichroism spectra displayed the typical shape (minima at 208nm and 222nm) of a well-folded, 
mostly !-helical protein. In addition, zinc- and nickel-selecase showed very similar spectra, thus confirming that 
metal replacement had no significant influence in the overall conformation of the protein (Suppl. Fig. 2d). 
Oligomerization could not be followed by this technique as protein concentrations higher than 0.50mg/ml gave an 
increase in noise (HT[V]) that precluded measurements (CD[mdeg]) at the far-UV region. The near-UV region, 
which is sensitive to changes in tertiary structure [40], was also explored but did not show any significant signal 
(data not shown). This is consistent with the protein not adopting a single structure, which would be compatible 
with the different oligomeric populations of selecase at 0.50mg/ml.  
SAXS experiments (Fig. 1d, Suppl. Table 4 and Suppl. Figs. 3-4), in turn, revealed that even at high 
concentrations (up to 65mg/ml) the protein did not aggregate. The experimental curves showed systematic 
variations in data when increasing protein concentration, i.e. the values for the radius of gyration (Rg), the forward 
scattering (I(0)/concentration), and the maximum dimension of the particle (Dmax) displayed a continuous growth, 
which confirmed that in solution the relative population of the oligomeric species was dependent on 
concentration. After Single Value Decomposition (SVD) analysis of the complete SAXS dataset, inspection of 
the eigenvector shapes and eigenvalues, as well as successive improvement of data description with an increasing 
number of eigenvectors indicated the presence of four species, which were assigned to monomers, dimers, 
tetramers, and octamers. In particular, the curves at the three lowermost concentrations assayed (0.15, 0.30, and 
0.63mg/ml) indicated a mixed population of monomers and dimers based on the crystallographic structures slc1 
and slc2 (see section 1.10 and below). A satisfactory description of the three curves, with "2 values of 0.78, 0.83, 
and 0.83, respectively, was obtained with monomer fractions of 0.70±0.10, 0.69±0.04, and 0.35±0.02, 
respectively (Fig. 1c). This result largely coincides with those of AUC at low concentrations (see Suppl. Table 3). 
Experimental SAXS curves at higher concentrations (1.2–65mg/ml) could not be interpreted in terms of the 
crystallographic structures due to the non-crystallized octamers present in solution. Analysis of SAXS curves 
measured for nickel-selecase rendered very similar results to those of zinc-selecase (data not shown). No signs of 
aggregation were observed here either at concentrations up to 50mg/ml. The SAXS profiles showed a 
concentration-dependent increase in the derived values of Rg, Dmax, and I(0)/concentration. The SVD analysis 
indicated a mixture of monomers, dimers, tetramers, and octamers. Finally, the OLIGOMER analysis of the first 
five curves (from 0.15mg/ml to 2.0mg/ml) could be properly described as a combination of slc1 and slc2 with 
relative populations for the monomer ranging from 0.94±0.06 to 0.23 ±0.01 at the minimum and maximum 
concentrations, respectively. 
Taken together, biophysical approaches in solution converged at the presence of discrete monomers, 
dimers, tetramers, and octamers, with higher concentrations leading to higher degrees of oligomerization but not 
indiscriminate aggregation or precipitation. This was consistent with the protein being concentrated in 
ultracentrifugal devices beyond 130mg/ml without precipitation. Concentrations at which monomeric selecase 
was predominant coincided with those of maximal enzymatic activity (0.2-0.3mg/ml; Fig. 1a), thus indicating that 
the monomer is the active species and that oligomers correspond in all cases to self-inhibiting species. This 
explained why higher enzyme concentrations yielded lower activity (Fig. 1a). Finally, simple dilution with buffer 
reversed oligomerization to yield monomers and restore activity. 
To identify the molecular determinants of this oligomeric behavior, we crystallized and solved the 
structure of wild-type selecase (Suppl. Table 5). It has been reported that crystalline forms of the MP 
carboxypeptidase displayed enzymatic activity [41], so crystal structures of enzymes adequately represent the 
active forms in solution. We obtained three crystal forms—orthorhombic, tetragonal, and hexagonal—, which 
serendipitously corresponded, respectively, to monomeric (slc1), dimeric (slc2) and tetrameric (slc4) forms of 
selecase. This indicated that at least three of the oligomerization states found in solution had a counterpart in the 
form of a stable, isolatable species, each one favored by particular crystallization conditions, which would mimic 
the effect of "growing" concentration and drive the system into the different oligomeric states [42]. The 
concentrations at which monomeric selecase was found in solution were insufficient for crystallization studies 
(generally >1-2mg/ml). To overcome this and obtain crystals of the monomeric form we replaced the catalytic 
zinc ion with divalent nickel, which rendered the enzyme inactive (see above and Suppl. Table 2). In general, this 
metal replacement does not affect the overall active-site geometry in MPs due to the shared divalent charge and 
similar ionic radii (nickel, 0.69Å; zinc, 0.74Å; see e.g. [38b]), so monomeric nickel-selecase can be considered as a 
valid structural model for the monomeric active zinc enzyme. This was supported by circular dichroism 
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experiments, analytical ultracentrifugation, SEC-MALLS, and SAXS, which indicated equivalence of zinc- and 
nickel-selecase (see above). We then incubated diluted monomeric nickel-selecase with an excess of a 
pentapeptide spanning the casein cleavage sequence (A-Y-F-Y-P) to saturate the active-site cleft and maintain its 
overall competent conformation, and subsequently concentrated the sample. This strategy yielded monomeric 
selecase at 11mg/ml, a concentration at which the protein is normally oligomeric (Suppl. Fig. 2a).  
The crystal structures of active monomeric wild-type selecase (slc1), and inactive dimeric (slc2) and 
tetrameric wild-type selecase (slc4; see Suppl. Table 5) show that both the N- and the C-terminus are flexible and 
surface located, thus explaining why N-terminally differing selecase variants give rise to equivalent enzymatic 
activity and crystals. In addition, interactions important for molecular cohesion in slc1 are provided by a charge-
relay system involving salt bridges K2-D60, E17-R64, and E61-R64 (all within a so-called N-terminal sub-domain 
(NTS), see main text), which is stabilized by the aliphatic side-chain part of K2 residing on a hydrophobic pillow 
made by L7, L55, and I63. Other cohering contacts include the central hydrophobic core of the protein (Suppl. 
Table 6), salt bridges E62-K105 and K75-E87 (both at the interface between NTS and the so-called C-terminal sub-
domain (CTS), see main text), and hydrogen bonds at the NTS-CTS interface between the side chains of R64 and 
K105 and the main-chain carbonyl oxygens of L91 and Y57, respectively. In slc2, the N-terminal stretch is somewhat 
more flexible than in slc1, as a result of which the charge-relay system is absent. Instead, D60 interacts with R64, 
which becomes reoriented for its side chain and no longer bridges E61 with E17. This, in turn, causes E61 to 
hydrogen-bond N94. In addition, major differences are found at N22-N26, which is part of L%1$1 in both slc1 and 
slc2. In slc4 the same differences as in slc2 are observed with respect to the NTS charge relay chain of slc1. There 
is just one additional interaction between R64 and N13 when compared with slc2. Given that both slc2 and slc4 are 
catalytically inert as inferable from the conformation of their active sites (see main text), the two constellations 
found for this charge relay in slc1 and slc2/slc4 could make the difference between competence and incompetence, 
respectively, in wild-type selecase. In addition, major differences are found in slc4 at L20-N26, which in the 
tetrameric protein adopts a helical structure (helix %A, see Suppl. Table 7). However, given that this loop also 
differs from slc1 in slc2, we attribute these differences to intrinsic variability of this surface-located region. 
The major conformational rearrangement observed in the three wild-type selecase structures mainly 
affects the CTS and the central trigger point is the sub-domain interface at G77. In all cases, the inactive species 
are characterized either by non-functional metal-binding sites and/or blocked active-site clefts—mainly on their 
non-primed sides—by repositioning of the C-terminal helices, which would hamper proper binding of peptide 
substrates. Interestingly, the position and side chain conformation of upstream residue Y76 are still very similar in 
all three structures. This indicates that selecase is composed of two basic folding units (foldons), respectively 
spanning the NTS and the CTS, so the mainly hydrophobic interface between sub-domains would act as a zipper 
to trigger reversible conformational rearrangements. The high mobility of the CTS was further confirmed by 
computational analysis of local conformational frustration, which identifies sites of mobility of a protein around 
its native basin [31]. These calculations identified segments spanning almost the entire CTS as highly frustrated in 
the three different wild-type selecase monomers (Suppl. Fig. 7). Consistently, analysis of inter-domain flexibility 
based on the elastic network model revealed potential hinge motions at the sub-domain junctions of each of the 
three structures at K75-Y76 (data not shown). 
The structural bases of the transitions between competent monomeric and incompetent dimeric/tetrameric 
autoinhibitory assemblies of wild-type selecase are consistent with calculated geometric and thermodynamic 
parameters (see Suppl. Table 8). In accordance with enzymatic activity corresponding to the most stable structure, 
slc1 has the lowest calculated solvation free energy of folding ("G=–109kcal/mol; [43]), which lies in the range 
described for well-folded structures (~–1kcal/mol per residue; [43]). Compactness, which further contributes to 
stability, is reflected by the slc1 monomer having the smallest accessible surface of all three conformers 
(6,999Å2). The slc2 protomer shows a similar value of "G (–105kcal/mol) but a larger overall surface (7,274Å2; 
4% larger than in slc1). Here, the incompetent quaternary structure is stabilized through dimerization, which 
yields a value of "G of –217kcal/mol for the dimer. This is more than twice the value of the slc2 monomer and 
coherent with a value of "Gdiss, the free energy of assembly dissociation [28], of 24kcal/mol, which, in turn, is 
consistent with typical free energies of dimerization in protein-protein complexes ranging between –11 and –
22kcal/mol [44]. Finally, the slc4 protomer has the lowest value of monomeric "G (–92kcal/mol) and largest 
accessible surface (8,696Å2; 24% larger than in slc1). Its overall stability is provided by the tetrameric 
arrangement and reflected by "G and "Gdiss values of –424kcal/mol (4.6 times higher than that of the slc4 
monomer) and 14kcal/mol, respectively. 
Given the importance of the C-terminal helix %4 and loop L$1$2 in the dimerization of slc2 and 
tetramerization of slc4 (see main text), we selected residues R36, I100, I103, and H107, which had been observed to 
participate in dimerization in slc2 and tetramerization in slc4, and generated a total of seven single, double and 
triple point mutants (R36W, I100F, I103E, H107F, I100F+H107F, I103E+H107F, I100F+I103E+H107F) to try to ablate the 
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interactions responsible for oligomerization and thus obtain monomeric forms. In addition, we constructed two 
deletion variants affecting %4, respectively lacking four (slc"C4) and eight (slc"C8) C-terminal residues. All 
protein variants were produced, purified, and concentrated similarly to the wild type except for slc"C4, which 
was obtained with lower yields and could only be maximally concentrated to 5.0mg/ml, and slc"C8, which was 
insoluble under the expression conditions tested and was thus discarded for further studies (see section 1.1). This 
finding pointed to a stabilizing effect of helix %4 on the whole protein despite its overall flexibility in the distinct 
structures analyzed (see main text). Inspection of the elution profiles of mutant and deletion variants in calibrated 
SEC at low concentration (0.50mg/ml) revealed no significant difference with the monomer-dimer equilibrium of 
the wild-type (Suppl. Fig. 5a). At high concentrations (5.0mg/ml; Suppl. Fig. 5b), all species displayed variable 
populations of dimers, tetramers, and octamers, with the notable exception of selecase mutants H107F and 
I100F+H107F, which were mainly tetramers. Cleavage assays at 0.25mg/ml and 5.0mg/ml, in turn, revealed activity 
similar to the wild type of all forms except for mutants H107F and I100F+H107F, which were less active because 
their oligomerization equilibrium is shifted towards tetramers at lower concentrations than the other forms (Suppl. 
Fig. 5c,d). In all cases, however, the activity at high concentration was lower than that at low concentration, as 
observed for the wild type. Accordingly, although mutation of the residues engaged in oligomerization in wild-
type selecase may produce a certain rearrangement in the distribution of the distinct oligomers, the four species 
are still observed and this is reflected by diminished activity upon concentration increase as in the wild type. 
Taken together, these results indicate that selecase is highly plastic, so it can adapt to potentially deleterious 
mutations affecting segments engaged in oligomerization and retain its capacity to oligomerize. This flexibility 
even tolerates ablation of four residues of the C-terminal helix, but ablation of eight residues destabilizes the 
protein and renders it insoluble. This is reminiscent of the related minigluzincin, proabylysin [17]. Out of all these 
variants, we managed to crystallize mutants R36W (termed slc2’; section 1.9) and I100F+H107F (termed slc2’’; 
section 1.9) and solve their structures (section 1.10 and Suppl. Table 5). Interface analysis with program PISA 
(see 1.11) clearly suggested that the oligomerization state of slc2’ was a dimer, with an interface area (dimer AB) 
of 1,152Å2, an "iG value (solvation free energy gain upon dimerization) of –15.4kcal/mol, a "iG P-value 
(probability of getting a lower "iG value) of 0.085, and a CSS score (complexation significance score; indicates 
for the contribution of an interface to assembly formation) of 0.818. The same analysis for slc2’’ likewise clearly 
suggested a dimer, with an interface area of 950Å2, an "iG value of –17.9kcal/mol, a "iG P-value of 0.028, and a 
CSS score of 0.636. Structural details are discussed in the main text. 
We further identified two close selecase orthologs from M. igneus and M. fervens, which had not been 
found in previous searches for minigluzincins [17]. These were much closer to selecase (81% and 95% sequence 
identity, respectively) than any other of the minigluzincin orthologs previously studied and could actually be 
considered as natural fivefold and 19-fold point mutants, respectively (Suppl. Fig. 6). We produced and purified 
them similarly to wild-type selecase (section 1.1), and analyzed their concentration-dependent oligomerization 
behavior and activity, as with the aforementioned selecase point mutants. They likewise evinced concentration-
dependent oligomerization, which was similar to selecase at low concentration (0.50mg/ml) for the M. fervens 
ortholog but rather displaced towards dimers in the M. igneus form (Suppl. Fig. 5a). At high concentrations 
(5.0mg/ml), both were mainly dimeric-tetrameric (Suppl. Fig. 5b). Interestingly, while both showed less activity 
against peptide CCS at high concentration than at low concentration as in selecase and its mutants (Suppl. Fig. 
5c,d), the M. igneus ortholog was much more active than the M. fervens form. This is consistent with the lower 
degree of identity with selecase of the latter than the former, thus pointing to potential differences in substrate 
specificity and activity. 
Finally, despite overall structure and sequence similarity of selecase with projannalysin and proabylysin 
(35% and 40% respective identity), the latter two minigluzincins could only be produced, isolated, and 
characterized as single conformers. These corresponded to inactive zymogens in which access of substrates to the 
cleft was blocked [17]. These zymogens were self-inhibited in two distinct and novel manners and any attempts to 
produce mutants and variants that would show activity or conformational changes failed despite extensive trials, 
so a function distinct to proteolysis for these two proteins cannot be ruled out. Interestingly, proabylysin is 
maintained latent inside the molecule by its own C-terminal stretch, which penetrates the—overall competent—
active-site cleft in extended conformation and contacts the catalytic metal through its C-terminal carboxylate 
group. In contrast, projannalysin—also in an overall competent conformation for its metal site and cleft—forms a 
dimer that is similar to that of slc2. In the former, however, the C-terminal carboxylate approaches the metal—as 
in proabylysin—and there is no ligand swap as in slc2. Overall, this points to a unique mechanism for latency 
maintenance via oligomerization through a fold-switch capacity of the specific metallocaseinase selecase that is 
shared with very close orthologs from M. igneus and M. fervens (~80-95% sequence identity) but not with other 
more distant homologs (~35-40% sequence identity), not even from the same organism (projannalysin). This 
system of autoinhibition, together with the highly selective specificity of selecase, has enabled, for the first time 
 12 
to our knowledge, intracellular overproduction in E. coli of a mature active peptidase in soluble functional state 
without affecting host cell growth. 
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5. SUPPLEMENTAL TABLES 
 
Suppl. Table 1. Inhibition of wild-type selecase activity. 
Inhibitor Concentration (mM) Specificity Relative activity (%) 
None 
EDTA 
ZnCl2 
Phosphoramidon 
Actinonin 
GM1489 
MMP inhibitor III 
MMP inhibitor V 
Batimastat 
Marimastat 
PMSF 
Pefabloc 
Benzamidine 
Iodoacetamide 
E-64 
Pepstatin A 
— 
1 
1 
0.25 
0.25 
0.05 
0.05 
0.25 
0.005 
0.25 
1 
1 
1 
1 
0.1 
0.1 
— 
Metallopeptidases 
Metallopeptidases 
Metallopeptidases 
Metallopeptidases 
Metallopeptidases 
Metallopeptidases 
Metallopeptidases 
Metallopeptidases 
Metallopeptidases 
Serine peptidases 
Serine peptidases 
Serine peptidases 
Cysteine peptidases 
Cysteine peptidases 
Aspartic peptidases 
100 
0 
3 
39 
6 
24 
5 
11 
2 
45 
82 
78 
66 
79 
94 
75 
Values as mean of three independent measurements, SD within ±5. Selecase 
concentration: 2µM. 
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Suppl. Table 2. Effect of divalent ions on wild-type apo-selecase reactivation. 
Cation Final concentration (mM) Relative activity (%) 
Zn2+ 
Co2+ 
Mg2+ 
Mn2+ 
Ca2+ 
Cd2+ 
Cu2+ 
Ni2+ 
0.01 
0.01 
0.01 
0.01 
0.01 
0.01 
0.01 
0.01 
100 
162 
4 
5 
4 
5 
16 
3 
Values as mean of three independent measurements, SD within ±5. Selecase 
concentration: 20µM 
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Suppl. Table 3. Analytical ultracentrifugation data of wild-type selecase. 
Sedimentation velocity Population of species 
0.03 mg/ml 
0.10 mg/ml 
0.30 mg/ml 
0.90 mg/ml 
3.0 mg/ml 
9.0 mg/ml 
18 mg/ml 
slc1 (76.0%), slc2 (24%) 
slc1 (70.6%), slc2 (29.4%) 
slc1 (55.9%), slc2 (33.7%), slc4 (10.4%) 
slc2 (53.0%), slc4 (34.5%), slc8 (12.5%) 
slc2 (24.8%), slc4 (47.2%), slc8 (28%) 
slc4 (32.6%), slc8 (67.4%) 
slc4 (20.9%), slc8 (79.1%) 
Equilibrium velocity Average mass (Da) (Ln(Mw/Mwapp) = 7.86 x #) 
0.03 mg/ml 
0.10 mg/ml 
0.30 mg/ml 
0.90 mg/ml 
3.0 mg/ml 
9.0 mg/ml 
18 mg/ml 
16,866 ± 192 
21,364 ± 96 
32,313 ± 204 
41,135 ± 164 
55,833 ± 240 
75,875 ± 356 
86,902 ± 460 
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Suppl. Table 4. Analysis of SAXS diffraction data of wild-type selecase. 
Conc. (mg/ml) Rg (Å) I(0)/conc Dmax (Å) 
0.15 17.7 8.07 60.5 
0.30 18.6 8.75 65.4 
0.63 20.6 12.86 72.2 
1.2 25.6 20.92 89.5 
1.9 28.9 21.79 96.9 
4.5 30.9 32.11 108.1 
8.5 36.1 46.35 126.2 
15 43.5 68.47 152.3 
22 50.4 81.14 176.5 
46 50.0 83.80 179.5 
65 47.3 79.44 181.0 
 
 
 1  
 
Suppl. Table 5. Crystallographic data. 
Dataset Tetragonal slc2 Hexagonal slc4 Orthorhombic slc1 Monoclinic slc2’ Orthorhombic slc2’’ 
Space group / cell constants (a, b, c, in Å)  P43212/ 43.53, 43.53, 128.13 P6422 / 102.2, 102.2, 59.4  P21212 / 51.26, 77.35, 31.11 P21 / 37.69, 101.09, 76.57, !=99.8º P212121 / 49.39, 49.84, 104.84 
Wavelength (Å) 0.9795 0.8726 0.8726 0.8726 0.9795 
No. of measurements / unique reflections 67,065 / 6,813 84,097 / 3,962 54,472 / 7,658 169,251 / 25,107 303,440 / 26,633 
Resolution range (Å) (outermost shell) a 43.5 – 2.20 (2.35 – 2.20) 49.3 – 3.00 (3.16 – 3.00) 42.7 – 2.10 (2.20 – 2.10) 42.0 – 2.30 (2.44 – 2.30)  52.4 – 1.75 (1.85 – 1.75) 
 
Completeness (%) 99.5 (97.6) 99.7 (99.7) 99.9 (99.3)  99.8 (99.7) 99.2 (95.1) 
Rmerge b 0.061 (0.649) 0.058 (0.881) 0.070 (0.868) 0.101 (0.998) 0.054 (0.851) 
Rmeas c / CC(1/2). d 0.064 (0.728) / 1.000 (0.829) 0.060 (0.914) / 1.000 (0.886) 0.076 (0.935) / 0.999 (0.852) 0.110 (1.083) / 0.999 (0.810) 0.056 (0.928) / 1.000 (0.701) 
Average intensity 
e
 23.4 (2.3) 32.4 (2.5)  17.7 (2.6) 15.0 (2.1) 24.4 (2.1) 
B-Factor (Wilson) (Å2) / Average multiplicity 49.0 / 9.8 (4.5) 114.2 / 21.2 (13.4)  45.5 / 7.1 (7.2) 51.0 / 6.7 (6.6) 35.8 / 11.4 (6.2) 
Resolution range used for refinement (Å) 41.2 – 2.20 49.3 – 3.00 42.7 – 2.10 42.0 – 2.30 52.4 – 1.75 
No. of reflections used (among them, test set) 6,765 (483) 3,952 (489) 7,658 (494)  25,107 (739) 26,632 (749) 
Crystallographic Rfactor (free Rfactor) b 0.219 (0.242) 0.200 (0.257) 0.208 (0.281)  0.222 (0.247) 0.185 (0.196) 
No. of protein atoms / ions 914 / 1 Zn2+ 906 / 1 Zn2+, 1 Na+ 914 / 1 Ni2+ 3,618 / 4 Zn2+, 1 Cl- 1,864 / 2 Zn2+ 
 solvent molecules / ligands 33 / 2 GOL  1 / 4 GOL 58 / 1 GOL 149 / 4 GOL 251 / 5 ACT, 1 GOL 
Rmsd from target values  
      bonds (Å)  /  angles (°) 0.010 / 0.99 0.010 / 1.13 0.010 / 1.01 0.009 / 1.11 0.010 / 1.03 
Aver. B-factors protein atoms (Å2) 50.9 125.2 49.7 62.3 36.6 
 
  
Residue main-chain conformational angle and  
side-chain rotamer analysis 
f 
      favored regions / outliers / all residues / 101 / 1 / 106 102 / 0 / 106 105 / 0 / 107 / 414 / 0 / 422 211 / 0 / 212 
      bad rotamers (%) / MolProbity score 12.6 / 2.27 (69th percent.) 5.83 / 2.14 (99th percent.) 1.92 / 1.26 (100th percent.)  6.59 / 2.02 (90th percent.) 3.40 / 1.76 (79st percent.) 
a
  Values in parentheses refer to the outermost resolution shell. 
 b  For definitions, see Table 1 in [45]. 
c
  According to Diederichs & Karplus [46]. 
d
  According to Karplus & 
Diederichs [47]. 
e
  According to program XDS/XSCALE. 
f
  According to MOLPROBITY [48]. GOL, glycerol; ACT, acetate.
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Suppl. Table 6. Residues contributing to the hydrophobic core and the sub-domain interface in slc1. 
NTS CTS 
!1 (I6, L7, I10, L11, T14, I15, L18) 
L!1"1 (L20, I27) 
"1 (I29, I31) 
"2 (I38, A39, I41) 
L"2"3 (L43) 
"3 (I48, I50) 
!B (I54, L55, Y57, L58) 
!2 (I63, F65, I66, L67, A68, L71, L72, L74, Y76) 
L!2!3 (L81) 
!3 (F84, L88, L91) 
L!3!4 (F92) 
!4 (K95, I98, L99, L102, L106) 
The respective regular secondary-structure elements are shown (see also Suppl. Table 7). Residues 
contributing to the NTS-CTS interface are underlined. 
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Suppl. Table 7. Regular secondary structure elements of selecase. 
Residue range Name Comments 
R4-N19 
N21-N26 
N28-K32 
I38-S42 
K46-I50 
K51-L58 
D60-Y76 
K78-N82 
N82-L91 
E87-L91 
N94-Q108 
“backing helix” !1 
!A 
"1 
"2 
"3 
“linking helix” !B 
“active-site helix” !2 
"4 
“glutamate helix” !3 
"5 
“C-terminal helix” !4 
 
In slc4, slc2’ and slc2’’ 
 
 
 
 
Till K75 in slc4 
Only in slc4 
Not in slc4 
Only in slc4 
Till H107 in slc1, slc2’ (B) and slc2’’ 
From K95 onwards in slc2’ (B) 
The nomenclature has been chosen to be compatible with that of projannalysin and proabylysin (see PDB 
4JIX and 4JIU; [17]). Helix !B was termed !1’ in projannalysin and topologically corresponded to 310-helix 
#1 in proabylysin.  
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Suppl. Table 8. Oligomerization and thermodynamic parameters of wild-type selecase. 
Pairwise close contacts
 a
 and surface complementarity (Sc)
 b 
Slc2 (molecule A – molecule B; sym. op. –Y, –X, –Z+1/2 
c
) 
34 symmetric close contacts (incl. 8 hydrogen bonds, 1 metallorganic contact, and 34 hydrophobic carbon-carbon contacts 
by 5 residues of each molecule). Segments involved in dimerization: 35-39, 53-57, 69-70, and 100-110. Sc=0.57 
Slc4 (molecule A – molecule B; sym. op. –Y+1, –X, –Z+4/3) 
42 symmetric close contacts (incl. 10 hydrogen bonds and 6 hydrophobic carbon-carbon contacts by 5 residues of each 
molecule). Segments involved in oligomerization: 34-38, 51-57, 69-70, and 91-107. Sc=0.76 
Slc4 (molecule A – molecule C; sym. op. Y, X+1, –Z+4/3) 
9 symmetric close contacts (all are hydrophobic carbon-carbon contacts made by 6 residues of each molecule). Segments 
involved in oligomerization: 95-106. Sc=0.80 
Slc4 (molecule A – molecule D; sym. op. –X, –Y+1, Z) 
40 symmetric close contacts (incl. 2 hydrogen bonds, 1 metallorganic contact, 1 metal-metal contact, and 25 hydrophobic 
carbon-carbon contacts by 17 residues of each molecule). Segments involved in oligomerization: 17-19, 38, 54-76, 93-
106, and 999 (metal ion). Sc=0.65 
Molecular and oligomerization analysis 
d 
 No. of 
atoms 
No. of 
residues 
Total 
surface 
(Å2) 
$G 
d,e
 
(kcal/mol) 
Residues (%) in 
regular secondary 
structure      
(! / " / total) 
Calculated oligomeric 
state 
d
 / 
$Gdiss(kcal/mol) 
f 
Interface 
buried 
(Å2) 
Slc1 (monomer) 914 109 6,999 -109 60 / 14 / 73 1 / -  
Slc2 (monomer) 907 108 7,274 -105 66 / 14/ 75 2 / 24  
Slc4 (monomer) 906 108 8,696 -92 61 / 23 / 80 4 / 14  
Slc2 (dimer) 1814 216 12,683 -217   2,130 g 
Slc4 (tetramer) 3,624 432 25,704 -424   9,850 
a
 According to program CNS [27]. 
b
 According to program SC [30]. 
c
 Sym. op. is the crystallographic operator that generates 
the symmetric molecule interacting with molecule A in the respective oligomer. Molecules B and D are neighbors of 
molecule A and molecule C is in opposite position it. 
d
 According to computational crystal-packing analysis with the PISA 
program, which has a success rate of 80-90% in the recovery of functional biological assemblies [28]. 
e $G is the solvation 
free energy of folding. 
f $Gdiss is the free energy of assembly dissociation. $Gdiss >0 is indicative of a thermodynamically 
stable assembly (see [28]). 
g
 This value is above the range generally described for protein-protein complexes (1600 ±350Å2; 
[49]). Data on slc2’ and slc2’’ have not been included as these variants are not the same chemical species as slc1, slc2, and 
slc4. 
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6. SUPPLEMENTAL FIGURES 
 
 
 
Suppl. Figure 1 – (A) SDS-PAGE of !-casein incubated with selecase (see section 1.2). Lane 1, molecular mass 
standard. Lane 2, selecase. Lane 3, !-casein consisting of !s2-casein (top light band; 25KDa) and !s1-casein 
(bottom strong band; 22-23.7KDa). Lane 4,  !-casein incubated with wild-type selecase leads to cleavage of !s1-
casein at a single site. Lanes 5, 6, 7, and 8,  !-casein incubated, respectively, with inactive active-site mutant E70A 
and wild-type selecase in the presence of EDTA, ZnCl2, and 1,10-phenanthroline (all at 1mM). (B) Coomassie-
stained zymogram of !-casein incubated for 48h at 37°C with 13.6-KDa and 16.5-KDa selecase (2.5µg; same for 
13.1-KDa selecase, data not shown) in the absence (left panel) and presence (right panel) of 5mM 1,10-
phenanthroline. Caseinolytic activity is detected as light lysis zones. Lane 1, molecular mass standard. Lane 2, 
active 13.6-KDa selecase. Lane 3, active 16.5-KDa selecase and its likewise active partial autolytic cleavage 
product, 13.8-KDa selecase (left panel only). Lane 4, inactive E70A 13.6-KDa selecase mutant. Lane 5, bovine 
trypsin (0.025µg) as positive control. (C) Proteolysis of peptide CCS at 10µM over time after incubation at 37°C 
in 50mM HEPES, 150mM NaCl, pH7.5 with either wild-type (WT) or E70A-mutant (E/A) 13.6-KDa selecase at 
2µM. Equivalent results were obtained with 13.1-KDa selecase (data not shown). (D) pH-Dependence of selecase 
cleavage activity on peptide CCS. 
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Suppl. Figure 2 – (A) Calibrated size-exclusion chromatography (SEC) of selecase at selected initial 
concentrations (0.15-50mg/ml; samples become diluted during this chromatography) plus aprotinin (arrow) as 
internal molecular-mass reference (6.5KDa; see section 1.4 for details). The peak pattern observed at each 
concentration corresponds to distinct populations of oligomeric selecase, for which the theoretical migration 
volumes are shown as vertical lines. Only concentrations at or below ~0.20mg/ml contain essentially monomeric 
selecase. The peak corresponding to the complex between nickel-selecase and a pentapeptide (see section 1.4) 
injected at 11mg/ml (asterisk; dotted line) elutes mainly as a monomer while unbound zinc-selecase at 10mg/ml 
(light blue trace) is mainly a dimer. (B) SEC coupled to multi-angle laser light scattering (SEC-MALLS) of 
selecase at selected initial concentrations (0.15-65mg/ml; samples become diluted during this chromatography). 
The peak pattern moves towards smaller elution volumes when increasing protein concentration, indicating 
protein oligomerization. Analysis of the absolute mass of the different peaks reveals two main species of ~25KDa 
and ~80KDa corresponding, respectively, to dimeric and octameric selecase. (C) Qualitative crosslinking 
experiment followed by SDS-PAGE depicting the population of selecase monomers (1), dimers (2), monomers 
linked with dimers (1+2), and tetramers (4) at increasing protein concentrations and 5-fold molar excess of 
crosslinker (BS3) at room temperature (Lanes 1-5, 0.25, 0.50, 2.0, 10 [all 10’], and 10mg/ml [12h], lane 6, 
molecular mass standard). (D) Far-UV circular dichroism spectra of zinc- and nickel-selecase. 
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Suppl. Figure 3 – (A) SAXS intensity profiles, I(s), as a function of the momentum transfer, s, measured for 
wild-type selecase at 11 concentrations (bottom to top): 0.l5 (yellow), 0.30, 0.63, 1.2, 1.9, 4.5, 8.5, 15, 22, 46 and 
65mg/ml (black). Profiles have been displaced along the I(s) axis for comparison. Variation of the primary SAXS 
data parameters with concentration: (B) Rg, (C) I(0)/concentration, and (D) Dmax. 
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Suppl. Figure 4 – Single Value Decomposition (SVD) analysis of the SAXS data measured for selecase. 
Eigenvectors (A) derived from the analysis sorted by their corresponding eigenvalues (B). (C) Agreement with 
the experimental data upon successive increase in the number of eigenvectors. 
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Suppl. Figure 5 – (A) Calibrated size-exclusion chromatography of seven selecase point mutants and a deletion 
variant at 0.50mg/ml initial concentration at injection (for color coding, see inset) and the orthologs from M. 
igneus (brown line) and M. fervens (light green line) as compared with the wild type (black line). See also Suppl. 
Fig. 2a. (B) Same as (A) but at 5.0mg/ml. (C) Cleavage activity of point mutants, deletion variant, and orthologs 
at 0.25mg/ml in front of peptide CCS compared with wild-type selecase. The curves have been normalized to the 
wild-type curve (in black), for which the scale on the ordinate is valid. Color coding as in (A). (D) Same as (C) 
but at 5.0mg/ml. 
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Suppl. Figure 6 – Sequence alignment of, top to bottom, selecase (UP Q58610) and two close orthologs from M. 
igneus (UP F6BCT9) and M. fervens (UP C7P7R3) performed using the MULTALIN program [19] at 
http://multalin.toulouse.inra.fr/multalin/multalin.html and represented using the ESPRIPT server [50] at 
http://espript.ibcp.fr/ESPript/ESPript. Numbering and regular secondary structure elements correspond to M. 
jannaschii slc1 (see also Suppl. Table 7). The sequence identity of each protein with the other two is indicated, 
respectively, in the lower alignment block after the UP code. 
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Suppl. Figure 7 - Analysis of local configurational frustration of the final slc1, slc2, and slc4 wild-type selecase 
monomers (top to bottom) with the FRUSTRATROMETER [31] at http://lfp.qb.fcen.uba.ar/embnet. Highly 
frustrated regions (red traces) include, respectively, segments 11-13, 79-90, and 95-100; segments 74-88 and 95-
99; and segments 57-63, 80-81, 85-88, 95-101, and 103-106. The common consensus region of frustration spans 
almost the entire CTS. Data on slc2’ and slc2’’ have not been included as these variants are not the same chemical 
species as slc1, slc2, and slc4. 
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7.  LEGENDS TO SUPPLEMENTAL MOVIES 
 
Suppl. Movie 1 – Movie to illustrate the transition between slc1 and slc2 monomers. The ribbon plot of slc1 is first 
shown in pink with its functional active-site environment. The cleft with the hydrophobic S1’ pocket is then 
depicted as a surface model colored according to Kyte-Doolittle hydrophobicity (blue=hydrophilic over white to 
orange=hydrophobic). The transition between slc1 (in pink) and slc2 (in blue) was generated with the morph 
option of program CHIMERA, i.e. it does not correspond to any empirically demonstrated trajectory. The 
transformation is correlated with a dimeric quaternary arrangement (chains in blue and yellow), which leads H107 
from the C-terminal helix of the symmetric molecule to replace H80 in the metal coordination sphere. 
 
Suppl. Movie 2 – Movie to illustrate the transition between slc1 and slc4 protomers. The ribbon plot of competent 
slc1 is shown in pink and its transformation to slc4 (in turquoise) was generated with the morph option of program 
CHIMERA, i.e. it does not correspond to any empirically demonstrated trajectory. The structure of slc4 is only 
stable due to the tetrameric quaternary structure (chains in turquoise, green, white and black), which gives rise to 
an autoinhibitory particle. The latter is traversed by a long cleft, which harbors four metal ions arranged as two 
dimetallic sites (shown as red spheres). A cut-through view of the particle surface provides insight into the 
channel, shown for the wall created by the turquoise and green monomers. The associated dimetallic site is 
pinpointed by a blue and a yellow sphere. Finally, the ribbon plot of the latter two monomers and cations is 
shown, followed by a close up view of the dimetallic site and the metal-binding residues. 
 
Suppl. Movie 3 – Movie to illustrate a possible transition between slc1 and slc2’ (molecule B) protomers. The 
ribbon plot of competent slc1 is shown in pink and its transformation to slc2’ molecule B (in green) was generated 
with the morph option of program CHIMERA, i.e. it does not correspond to any empirically demonstrated 
trajectory. The oligomeric structure of slc2’ is a chemically identical but conformationally heterogenic dimer 
comprising a modified molecule B (green) and one with close-to-functional overall conformation similar to slc1 
(molecule A; orange ribbon). Dimerization is triggered by flipping in the tryptophan side chains of position 36 
and results in H107 from the C-terminal helix of the modified molecule binding the catalytic zinc ion as fourth 
intramolecular protein ligand. Inhibition of the second molecule is achieved by blocking access to the active-site 
cleft within the dimer. 
